Gulf Pharmaceutical Industries P.S.C. Overview
Pro stress-test →Gulf Pharmaceutical Industries manufactures and sells medicines, injections, and consumer healthcare products with specialization in wound care, cardiovascular, diabetes solutions, and pain management. The company operates through a network of more than 10 manufacturing plants and maintains approximately 800 products in various dosage forms.
Strategic Profile
Pro stress-test →The company has demonstrated a strong financial turnaround, becoming profitable with net income reaching AED 166.7 million for the first nine months of 2025. Short-term assets comfortably cover both short and long-term liabilities while debt levels are well-managed with a satisfactory net debt to equity ratio of 1%. The company's P/E ratio of 21.9x is below the industry average, indicating potential value for investors.
Competitive Landscape
Pro stress-test →Gulf Pharmaceutical competes in the UAE pharmaceutical market with a diverse portfolio targeting major therapeutic segments including endocrinology, anti-infective, cardiovascular and gastroenterology. Competition includes regional and international pharma manufacturers serving GCC markets.
Industry Context
Gulf Pharmaceutical Industries P.S.C. operates in Pharmaceutical Manufacturing & Healthcare Products.
Key facts
Founded: 1980 · Headquarters: Ras Al Khaymah, UAE · Employees: 2,400